US-based ARS’s nasal spray to treat allergic reactions gets FDA nod
ARS Pharmaceuticals, a US-based biopharmaceutical company, got the nation’s drug regulator’s approval for a nasal spray to treat allergic reactions in adult and.
Drugs
Health
Pharma
Drugs
Health
Pharma
Eli Lilly to acquire Dice Therapeutics by third quarter for $2.4 billion
HQ Team June 20, 2023: Eli Lilly and Company will acquire Dice Therapeutics for $2.4 billion to expand its immunology business, according to an.
Drugs
Health
Medical
`Immunologic memory’ behind HIV inflammation: Study
Patients living with HIV are at an increased risk of developing chronic inflammation due to “immunologic memory,” according to a study